Blue Cross Blue Shield - Iowa policy updates
Track new and updated Blue Cross Blue Shield - Iowa policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Intravenous Immune Globulin (IVIG) — indications and authorization criteria | Blue Cross Blue Shield - Iowa | Clinical | Immunology/Rheumatology | Modified | Aug 28, 2026 |
| Wegovy (semaglutide) — Supplemental Indications (cardiovascular risk reduction and MASH) | Blue Cross Blue Shield - Iowa | Clinical | Pharmacy & Specialty Drugs | Modified | Aug 15, 2026 |
| Kineret (anakinra) — Coverage Criteria | Blue Cross Blue Shield - Iowa | Clinical | Immunology/Rheumatology | Modified | Aug 14, 2026 |
| Multiple Sclerosis — Disease‑Modifying Therapies | Blue Cross Blue Shield - Iowa | Clinical | Neurology/Neurosurgery | Modified | Aug 11, 2026 |
| Kerendia (finerenone) — Coverage Criteria | Blue Cross Blue Shield - Iowa | Clinical | Nephrology | Modified | Aug 5, 2026 |
| Formulary Medical Necessity Program | Blue Cross Blue Shield - Iowa | Clinical | Pharmacy & Specialty Drugs | Modified | Aug 1, 2026 |
| Enzyme Replacement Therapy (Coverage Criteria) | Blue Cross Blue Shield - Iowa | Clinical | Immunology/Rheumatology | Modified | Jul 31, 2026 |
| Esbriet (pirfenidone) for idiopathic pulmonary fibrosis | Blue Cross Blue Shield - Iowa | Clinical | Pulmonology | Modified | Jul 29, 2026 |
| Increlex (mecasermin) — Coverage Criteria for Severe Primary IGF-1 Deficiency | Blue Cross Blue Shield - Iowa | Clinical | Endocrinology | Modified | Jul 29, 2026 |
| Immediate Release Opioid Analgesics (Brand and Generic): Acute Pain Duration Limit with MME Limit and Post Limit Policy | Blue Cross Blue Shield - Iowa | Clinical | Pain Management | Modified | Jun 13, 2026 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.